501 related articles for article (PubMed ID: 20079141)
1. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
Ren JP; Zhao YW; Sun XJ
Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
[TBL] [Abstract][Full Text] [Related]
2. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
[TBL] [Abstract][Full Text] [Related]
3. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
Kang MJ; Gil SJ; Koh HC
Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
[TBL] [Abstract][Full Text] [Related]
4. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
5. Selective vulnerability of the striatal subregions of C57BL/6 mice to paraquat.
Kang MJ; Gil SJ; Lee JE; Koh HC
Toxicol Lett; 2010 Jun; 195(2-3):127-34. PubMed ID: 20307631
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
7. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
10. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.
Mu X; He GR; Yuan X; Li XX; Du GH
Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
12. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Jourdain S; Morissette M; Morin N; Di Paolo T
J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
Sharma A; Kaur P; Kumar V; Gill KD
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
[TBL] [Abstract][Full Text] [Related]
14. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
Liou HH; Chen RC; Chen TH; Tsai YF; Tsai MC
Toxicol Appl Pharmacol; 2001 Apr; 172(1):37-43. PubMed ID: 11264021
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
17. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
[TBL] [Abstract][Full Text] [Related]
20. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
